Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

被引:23
|
作者
Kanaoka, Koshiro [1 ,2 ]
Onoue, Kenji [1 ]
Terasaki, Satoshi [1 ]
Nakano, Tomoya [1 ]
Nakai, Michikazu [2 ]
Sumita, Yoko [2 ]
Hatakeyama, Kinta [3 ]
Terasaki, Fumio [5 ]
Kawakami, Rika [1 ]
Iwanaga, Yoshitaka [2 ]
Miyamoto, Yoshihiro [4 ]
Saito, Yoshihiko [1 ]
机构
[1] Nara Med Univ, Dept Cardiovasc Med, Kashihara, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Dept Med & Hlth Informat Management, Suita, Osaka, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan
[4] Natl Cerebral & Cardiovasc Ctr, Open Innovat Ctr, Suita, Osaka, Japan
[5] Osaka Med & Pharmaceut Univ, Med Educ Ctr, Takatsuki, Japan
基金
日本学术振兴会;
关键词
biopsy; myocarditis; risk factors; VENTRICULAR ENDOMYOCARDIAL BIOPSY; SOCIETY; PREDICTORS; MANAGEMENT; STATEMENT; DIAGNOSIS; SURVIVAL;
D O I
10.1161/CIRCULATIONAHA.121.058869
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Fulminant myocarditis presentation (FMP) is a rare and severe presentation of myocarditis. The natural history of FMP and its clinical features associated with poor outcomes are incompletely understood because there is a lack of generalizable evidence. METHODS: This multicenter retrospective cohort study included patients hospitalized with histologically proven myocarditis who underwent catecholamine or mechanical support from 235 cardiovascular training hospitals across Japan between April 2012 and March 2017. Clinical features and the prognostic predictors of death or heart transplantation within 90 days on the basis of clinical and pathologic findings were determined using the Kaplan-Meier method, log-rank test, and Cox regression analysis. RESULTS: This study included 344 patients with histologically proven FMP (median age, 54 years; 40% female). The median follow-up was 600 days (interquartile range, 36 to 1599 days) and the cumulative risk of death or heart transplantation at 90 days was 29% (n=98). Results from multivariable Cox regression analysis showed that older age, nonsinus rhythm, low left ventricular wall motion (<40%) on admission, and ventricular tachycardia or fibrillation on admission day were associated with worse 90-day survival. Severe histologic damage (damaged cardiomyocytes comprising >= 50% of the total cardiomyocytes) was associated with a worse 90-day prognosis in patients with lymphocytic myocarditis. CONCLUSIONS: The results from analyses of data from this multicenter registry demonstrated that patients with FMP are at a higher risk of death or heart transplantation in real-world settings. These observations inform which clinical and pathologic findings may be useful for prognostication in FMP.
引用
收藏
页码:1425 / 1433
页数:9
相关论文
共 50 条
  • [1] Fulminant myocarditis proven by early biopsy and outcomes
    Huang, Florent
    Ammirati, Enrico
    Ponnaiah, Maharajah
    Montero, Santiago
    Raimbault, Victor
    Abrams, Darryl
    Lebreton, Guillaume
    Pellegrino, Vincent
    Ihle, Joshua
    Bottiroli, Maurizio
    Persichini, Romain
    Barrionuevo-Sanchez, Marisa Isabel
    Ariza-Sole, Albert
    Ng, Pauline Yeung
    Sin, Simon Wai Ching
    Ayer, Raj
    Buscher, Hergen
    Belaid, Slimane
    Delmas, Clement
    Ferreira, Rita
    Albuquerque Jr, Roberto Roncon
    Lopez-Sobrino, Teresa
    Bunge, Jeroen J. H.
    Fisser, Christoph
    Franchineau, Guillaume
    Mccanny, Jamie
    Ohshimo, Shinichiro
    Sionis, Alessandro
    Hernandez-Perez, Francisco Jose
    Barge-Caballero, Eduardo
    Balik, Martin
    Muglia, Henrique
    Park, Sunghoon
    Donker, Dirk W.
    Porral, Beatriz
    Aissaoui, Nadia
    Dessap, Armand Mekontso
    Burgos, Virginia
    Lesouhaitier, Mathieu
    Fried, Justin
    Jung, Jae-Seung
    Rosillo, Sandra
    Scherrer, Vincent
    Nseir, Saad
    Winszewski, Hadrien
    Jorge-Perez, Pablo
    Kimmoun, Antoine
    Diaz, Rodrigo
    Combes, Alain
    Schmidt, Matthieu
    EUROPEAN HEART JOURNAL, 2023, 44 (48) : 5110 - 5124
  • [2] Cardiac magnetic resonance in histologically proven eosinophilic myocarditis
    Poyhonen, Pauli
    Ragback, Johanna
    Mayranpaa, Mikko I.
    Nordenswan, Hanna-Kaisa
    Lehtonen, Jukka
    Shenoy, Chetan
    Kupari, Markku
    JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2023, 25 (01)
  • [3] Cardiac magnetic resonance in histologically proven eosinophilic myocarditis
    Pauli Pöyhönen
    Johanna Rågback
    Mikko I. Mäyränpää
    Hanna-Kaisa Nordenswan
    Jukka Lehtonen
    Chetan Shenoy
    Markku Kupari
    Journal of Cardiovascular Magnetic Resonance, 25
  • [4] Outcome of histologically-proven fulminant versus acute non-fulminant myocarditis with left ventricular systolic dysfunction. Evidence from the International Registry on Acute Myocarditis
    Ammirati, E.
    Veronese, G.
    Brambatti, M.
    Merlo, M.
    Potena, L.
    Okumura, T.
    Pinney, S.
    Braun, O.
    Van De Heyning, C. M.
    Montero, S.
    Shimokawa, H.
    Sinagra, G.
    Adler, E.
    Frigerio, M.
    Camici, P. G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1389 - 1389
  • [5] Society for cardiovascular pathology journal club: fulminant myocarditis proven by early biopsy and outcomes
    Giordano, Carla
    CARDIOVASCULAR PATHOLOGY, 2024, 69
  • [6] Fulminant myocarditis proven by early biopsy and outcomes (vol 44, pg 5110, 2023)
    Huang, Florent
    Ammirati, Enrico
    Ponnaiah, Maharajah
    Montero, Santiago
    Raimbault, Victor
    Abrams, Darryl
    Lebreton, Guillaume
    Pellegrino, Vincent
    Ihle, Joshua
    Bottiroli, Maurizio
    Persichini, Romain
    Barrionuevo-Sanchez, Marisa Isabel
    Ariza-Sole, Albert
    Ng, Pauline Yeung
    Sin, Simon Wai Ching
    Ayer, Raj
    Buscher, Hergen
    Belaid, Slimane
    Delmas, Clement
    Ferreira, Rita
    Roncon-Albuquerque Jr, Roberto
    Lopez-Sobrino, Teresa
    Bunge, Jeroen J. H.
    Fisser, Christoph
    Franchineau, Guillaume
    McCanny, Jamie
    Ohshimo, Shinichiro
    Sionis, Alessandro
    Hernandez-Perez, Francisco Jose
    Barge-Caballero, Eduardo
    Balik, Martin
    Muglia, Henrique
    Park, Sunghoon
    Donker, Dirk W.
    Porral, Beatriz
    Aissaoui, Nadia
    Dessap, Armand Mekontso
    Burgos, Virginia
    Lesouhaitier, Mathieu
    Fried, Justin
    Jung, Jae-Seung
    Rosillo, Sandra
    Scherrer, Vincent
    Nseir, Saad
    Winszewski, Hadrien
    Jorge-Perez, Pablo
    Kimmoun, Antoine
    Diaz, Rodrigo
    Combes, Alain
    Schmidt, Matthieu
    EUROPEAN HEART JOURNAL, 2024, 45 (05) : 375 - 375
  • [7] Clinical features of the fulminant myocarditis
    Xie, Jianchang
    Wang, Ningfu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C222 - C222
  • [8] Microthrombosis as a cause of fulminant myocarditis-like presentation with COVID-19 proven by endomyocardial biopsy
    Nakatani, Satoshi
    Ohta-Ogo, Keiko
    Nishio, Mayu
    Amemiya, Kisaki
    Sato, Shuho
    Sawano, Hirotaka
    Hatakeyama, Kinta
    Katano, Harutaka
    Suzuki, Tadaki
    Hirooka, Keiji
    CARDIOVASCULAR PATHOLOGY, 2022, 60
  • [9] Treatment and outcome of biopsy-proven fulminant myocarditis in adults
    Chau, EMC
    Chow, WH
    Chlu, CSW
    Wang, E
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (03) : 405 - 406
  • [10] Endosonographic Features of Histologically Proven Gastric Ectopic Pancreas
    Chou, Jen-Wei
    Cheng, Ken-Sheng
    Ting, Chun-Fu
    Feng, Chun-Lung
    Lin, Yu-Ta
    Huang, Wen-Hsin
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014